jcm-logo

Journal Browser

Journal Browser

Perspectives in Atrial Fibrillation: Managing Comorbidities, Recurrence, and Therapies

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: closed (31 March 2025) | Viewed by 1542

Special Issue Editor


E-Mail Website
Guest Editor
Heart and Vascular Centre, Semmelweis University, 1122 Budapest, Hungary
Interests: cardiology; cardiac imaging; coronary artery disease; cardio-oncology

Special Issue Information

Dear Colleagues,

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia that poses significant challenges due to its association with various comorbidities, high recurrence rates, and the complexities of its management. This Special Issue, “Perspectives in Atrial Fibrillation: Managing Comorbidities, Recurrence, and Therapies”, aims to provide a comprehensive overview of the current landscape in AF management. This Special Issue will explore the multifaceted nature of AF, delving into the intricacies of managing associated comorbidities such as hypertension, coronary artery disease, diabetes, heart failure, and cancer. Additionally, it will address strategies to prevent recurrence, including lifestyle modifications, pharmacological interventions, and procedural approaches like catheter ablation. This Special Issue will also highlight advancements in therapeutic options, examining the efficacy and safety of novel anticoagulants, antiarrhythmic drugs, and emerging technologies. By compiling cutting-edge research and expert opinions, this Special Issue seeks to enhance our understanding of AF and improve patient outcomes through more effective management strategies.

Dr. Zsofia Dora Drobni
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atrial fibrillation
  • comorbidities
  • recurrence
  • therapies
  • catheter ablation
  • anticoagulants
  • antithrombotic

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

23 pages, 2510 KiB  
Review
Management of Atrial Fibrillation in Elderly Patients: A Whole New Ballgame?
by Iris Parrini, Fabiana Lucà, Carmelo Massimiliano Rao, Roberto Ceravolo, Sandro Gelsomino, Carlo Ammendolea, Laura Pezzi, Nadia Ingianni, Donatella Del Sindaco, Adriano Murrone, Giovanna Geraci, Claudio Bilato, Giuseppe Armentaro, Angela Sciacqua, Carmine Riccio, Furio Colivicchi, Massimo Grimaldi, Fabrizio Oliva and Michele Massimo Gulizia
J. Clin. Med. 2025, 14(7), 2328; https://doi.org/10.3390/jcm14072328 - 28 Mar 2025
Cited by 1 | Viewed by 1253
Abstract
Atrial fibrillation (AF) is the most prevalent sustained supraventricular arrhythmia, particularly in older adults, with its incidence increasing dramatically with age. This condition is a significant contributor to morbidity and mortality, being closely linked to an elevated risk of heart failure, ischemic stroke, [...] Read more.
Atrial fibrillation (AF) is the most prevalent sustained supraventricular arrhythmia, particularly in older adults, with its incidence increasing dramatically with age. This condition is a significant contributor to morbidity and mortality, being closely linked to an elevated risk of heart failure, ischemic stroke, systemic thromboembolism, and dementia. The complexities of managing AF in the elderly arise from age-related physiological changes, comorbidities, frailty, and the challenges of polypharmacy. Therapeutic strategies must balance efficacy and safety, tailoring interventions to the individual’s health status, life expectancy, and personal preferences. This review explores the latest evidence-based approaches to managing AF in elderly patients, focusing on the nuanced application of rate and rhythm control strategies, anticoagulation, and emerging insights into the relationship between AF and cognitive impairment. Full article
Show Figures

Figure 1

Back to TopTop